📈 Price History

Ratio Health

— Excellent

— Good

— Average

— Poor

By Category

📊 Peer Medians

About

Advanced Drainage Systems, Inc. designs, manufactures, and markets thermoplastic corrugated pipes and related water management products in the United States, Canada, and internationally. The company operates through Stormwater and Wastewater segments. The company offers single, double, and triple wall corrugated polypropylene and polyethylene pipes; plastic leachfield chambers and systems; EZflow synthetic aggregate bundles; wastewater purification through mechanical aeration wastewater; septic tanks and accessories; combined treatment and dispersal systems, including AeroFin, advanced enviro-septic, enviro-septic, and advanced treatment leachfield; and allied products, including storm retention/detention and septic chambers, polyvinyl chloride drainage structures, fittings, and water quality filters and separators. It also purchases and distributes construction fabrics and other geosynthetic products for soil stabilization, reinforcement, filtration, separation, erosion control, and sub-surface drainage, as well as drainage grates and other products. In addition, the company provides PVC hubs, rubber sleeves, and stainless-steel bands; and channel drains, catch basins, grates, access boxes, and accessories engineered to capture, convey, and disperse stormwater. It offers its products for non-residential, residential, agriculture, and infrastructure applications through a network of distribution centers. Advanced Drainage Systems, Inc. was incorporated in 1966 and is headquartered in Hilliard, Ohio.

Key Ratios Snapshot

📈 Growth Pattern

⚡ Latest Quarter —

See full financials →

📊 Quick Scorecard

Loading…

🔍 Concall Decoded

🎙 Management Tone Tracker Confident Specific ↑ Improving 4 quarters analysed

Q1 2026

Mixed

Management is confident and specific about their own execution and margin resilience (e.g., 'strong results', '33.5% adjusted EBITDA margin among the highest in history'), but repeatedly expresses caution on the demand environment, using words like 'tepid', 'challenging', 'uncertain', and 'worried about demand'.

Q2 2026

Confident Specific

Management used upbeat language like 'executed well', 'strong margins', 'very pleased', and provided detailed metrics (e.g., 33.8% EBITDA margin, 9% revenue growth, 17% EBITDA growth). They emphasized control over controllable factors and clear strategies.

Q3 2026

Confident Specific

The CEO explicitly states 'strong results in a challenging market environment' and 'one of the most profitable third quarters in our history' with a 30.2% Adjusted EBITDA margin. Specific metrics are provided throughout (Allied +8%, Infiltrator +2%, Adj EBITDA +9%, etc.) and guidance is raised.

Q4 2026 latest

Confident Specific

Management repeatedly used strong language like 'excellent financial performance', 'exceeding the top end of both our revenue and adjusted EBITDA guidance ranges', and 'strong results'. They gave specific numbers for revenue, margins, and guidance ranges, and openly discussed challenges like inflation and air pocket risks.

Guidance Reliability Pending · <3Q data

Investor Lens

The investment thesis is stronger after this call, as management demonstrated consistent execution and resilience in a challenging demand environment, beating revenue and EBITDA guidance. The clear plan to manage inflation through pricing, recycling, and fleet economics reinforces competitive advantages. However, the flat volume guidance and expected 'air pocket' from pre-buying introduce near-term uncertainty. The successful NDS integration and cross-selling potential provide medium-term growth optionality, while a strong balance sheet (1.6x leverage) supports capital returns. Key watch items for next quarter are actual Q1 revenue patterns, the pace of price/cost matching, and visibility on NDS synergy realization. Overall, the company appears well-positioned to weather headwinds and emerge stronger.

AI-generated concall tone analysis · Updated 2026-06-08 · Not investment advice

📐

3-Statement Financial Model

Bear / Base / Bull projections · DCF fair value · Reverse-DCF

Open Model →

🎙 Management Tone Confident Specific ↑ Improving 4 quarters Full tone analysis in Intelligence →

📊 MIXED Advanced Drainage Systems posts Q4 revenue $677M, adjusted EBITDA margin 27.8%, guides FY2027 $3.35B-$3.55B revenue.

Revenue & Profitability

Q4 FY2026 revenue increased 10% year-over-year to $677 million. Adjusted EBITDA for the quarter was 27.8% of revenue. For the full fiscal year, adjusted EBITDA margin was 31.6%, the second highest in company history. Free cash flow for the year was $569 million, compared to $369 million in the prior year. The company generated $819 million in cash from operations, representing an 85% conversion of adjusted EBITDA.

Outlook

Management sees overall demand in FY2027 similar to FY2026, with a slightly more negative outlook for agriculture and single-family housing. Non-residential is expected to be flat to up low single digits, supported by large projects like data centers. Residential remains under pressure from interest rates and uncertainty, but the company expects to outperform the market. The R&R market is expected to remain resilient.

Growth Drivers

Key growth levers include Allied Products (up 12% organically in Q4), advanced treatment systems (Orenco), tank products (double-digit growth), and cross-selling opportunities following the NDS acquisition. Agriculture sales grew 30% in Q4 due to pre-buying ahead of price increases. The company is expanding its recycling capacity in the Southeast and investing in automation and production lines.

Balance Sheet & CapEx

In FY2026, capital expenditures were $250 million, focused on growth initiatives in key geographies, customer service, productivity, automation, expanding Infiltrator production capacity, and increasing recycling capacity in the Southeast. No explicit CapEx guidance was given for FY2027. The company also refinanced near-term maturities and increased its revolving credit facility to $750 million.

Margins

Adjusted EBITDA margin for Q4 was 27.8%, reflecting favorable growth, product mix, price-cost, and operational self-help. For the full year, adjusted EBITDA margin was 31.6%. Management expects FY2027 margins to face dilution from dollar-for-dollar pricing actions to offset inflation, with the timing causing some choppiness. SG&A is expected to be around 14% of revenue, down from 15%+ in FY2026, providing leverage.

Key Risks

Key risks flagged include significant inflation on diesel and common carrier rates, which impacted transportation costs in Q4. Customers buying ahead of price increases could create an 'air pocket' in demand during the summer. Geopolitical uncertainty and interest rate dynamics continue to pressure single-family housing. The company also noted potential volume compression in agriculture and residential land development projects.

Generated by AI · Q4 2026 results · Not investment advice

✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter

🔍

🔎 See cross-company document search → ?

📞 Earnings Call Transcripts (5)

Q1 2027 Q1 2027 2026-08-06

Record Q1 revenue and EBITDA were driven by strong stormwater and wastewater growth, disciplined price-cost management, and NDS integration. Despite inflationary headwinds, guidance is maintained, with continued investment in recycling and automation, and robust capital returns to shareholders.

Q4 2026 Q4 2026 2026-05-21

Strong fiscal 2026 results driven by diversified growth, robust free cash flow, and successful NDS integration. Fiscal 2027 guidance anticipates flat to modest growth amid inflationary pressures, with continued margin resilience and capital deployment for growth and shareholder returns.

Q3 2026 Q3 2026 2026-02-05

Delivered record profitability with a 30.2% Adjusted EBITDA margin and raised fiscal 2026 guidance, driven by strong Allied and Infiltrator product growth, successful NDS acquisition, and disciplined capital allocation. Non-residential sales outperformed, while residential remained soft.

Q2 2026 Q2 2026 2025-11-06

Second quarter results showed 9% revenue and 17% adjusted EBITDA growth, with a 33.8% margin, driven by strong execution, new products, and stable pricing. Guidance for fiscal 2026 was raised, but management remains cautious due to demand uncertainty and seasonality.

Q1 2026 Q1 2026 2025-08-07

Q1 delivered a 2% revenue increase and a 33.5% adjusted EBITDA margin, driven by strong performance in higher-margin segments and disciplined cost management. Guidance remains unchanged amid tepid demand, with continued investment in innovation and capacity.

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯

Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.

📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.